print PRINT

SCIENCE > Health

Japan lags behind in global COVID-19 vaccine race

  • March 25, 2021
  • , Mainichi
  • JMH Summary

Mainichi reported that Japan has run into difficulties securing coronavirus vaccines due to the EU’s accelerated moves to limit shipments to nonmembers and delays in development by Japanese pharmaceutical companies. The daily explained that the GOJ’s plan to secure 100 million doses of the Pfizer vaccine by the end of June is contingent on Brussel’s authorization, with an unnamed senior GOJ official saying that Tokyo failed to forecast such restrictions when putting together the vaccination program beginning late last year. The paper attributed the slow development of Japanese vaccines to the government’s failure to assist local manufacturers in investing in innovative vaccine technology.

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan